ArticlePatient preference and adherence2025
Predictors of Blood Pressure, Cholesterol, and Cardiovascular Screening Among Saudis at Primary Healthcare Settings in Riyadh, Saudi Arabia.
Article in Patient preference and adherence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Saudi Heart Association Scientific Statement on Cardiovascular-Kidney-Liver-Metabolic (CKLM) Syndrome.Journal of the Saudi Heart Association · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study was conducted to estimate proportion of individuals undergoing screening for cardiovascular disease (CVD) and its risk factors and to identify predictors of CVD, blood pressure, and blood cholesterol screening. Patients and Methods: This cross-sectional study was conducted in 48 primary healthcare centers in Saudi Arabia and 14,239 participants were enrolled. The analysis was performed in SPSS version 26 and adjusted odds ratios (AOR) and 95% Cis were reported. Results: Blood pressure screening was reported by 35.3%, cholesterol screening by 9.3%, and cardiovascular screening by 3.7%. Significant positive predictors for blood pressure screening included older age (50-75 years: AOR 1.34, 95% CI: 1.20-1.50; ≥75 years: AOR 2.12, 95% CI: 1.84-2.43), being married (AOR: 1.15; 95% CI: 1.04-1.27), non-smoking (AOR: 1.97; 95% CI: 1.79-2.17), physical activity (AOR: 1.16; 95% CI: 1.05-1.28), and diabetes (AOR: 2.14; 95% CI: 1.88-2.44). For cholesterol screening, significant positive predictors were older age (≥75 years: AOR 1.89, 95% CI: 1.56-2.29), unemployment (AOR: 1.26; 95% CI: 1.10-1.45), insurance coverage (AOR: 1.52; 95% CI: 1.33-1.74), smoking (AOR: 1.32; 95% CI: 1.14-1.53), diabetes history (AOR: 1.33; 95% CI: 1.09-1.61), and hypertension (AOR: 1.66; 95% CI: 1.36-2.02). For cardiovascular screening, significant positive predictors included older age (≥75 years: AOR 1.81, 95% CI: 1.35-2.43), unemployment (AOR: 1.53; 95% CI: 1.24-1.88), insurance coverage (AOR: 1.56; 95% CI: 1.27-1.92), smoking (AOR: 1.89; 95% CI: 1.52-2.34), diabetes (AOR: 1.85; 95% CI: 1.41-2.43), and high cholesterol (AOR: 1.76; 95% CI: 1.31-2.36). Conclusion: A very low proportion of Saudi residents have undergone blood pressure, cholesterol, and CVD screening. Common predictors of screening included older age, insurance coverage, diabetes, hypertension, physical activity, and high cholesterol levels. Low prevalence of screening is alarming, and Saudi Government needs to implement strategies that can help increase proportion of Saudi residents who receive blood pressure, cholesterol, and CVD screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.